Meng T, Zhou W, Li B, Yin H, Li Z, Zhou L, Kong J, Yan W, Yang X, Liu T, Song D, Xiao J (2015) En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review. World J Surg Oncol 13:176
Goljanek-Whysall K, Tridimas A, McCormick R, Russell NJ, Sloman M, Sorani A, Fraser WD, Hannan FM (2018) Identification of a novel loss-of-function PHEX mutation, Ala720Ser, in a sporadic case of adult-onset hypophosphatemic osteomalacia. Bone 106:30–34
Alonso G, Varsavsky M (2016) Tumour-induced osteomalacia: an emergent paraneoplastic syndrome. Endocrinol Nutr 63(4):181–186
Alvarez-Rivas N, Vazquez-Rodriguez TR, Garcia-Porrua C (2019) Tumor-induced hypophosphatemic osteomalacia: description of 2 cases. Med Clin (Barc) 152(1):e3–e4
Chen N, Zhang JB, Zhang Q, Zhao YP, Li LY, Liu LW, Yu F, Yu X, Peng T, Tang KX (2018) Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series. BMC Pharmacol Toxicol 19(1):23
Zhu S, Yang YH, Gao RW, Li R, Zou YZ, Feng L, Zhang B (2017) Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil. Drug Des Devel Ther 12:41–45
Kim JH, Jin HY, Baek HS, Lee KA (2018) Hypophosphatemic osteomalacia with multiple bone fractures: ADV-induced Fanconi’s syndrome. Chonnam Med J 54(1):78–79
Mills ES, Iorio L, Feinn RS, Duignan KM, Macica CM (2018) Joint replacement in X-linked hypophosphatemia. J Orthop 16(1):55–60
Moon NH, Shin WC, Do MU, Cho HJ, Suh KT (2018) An uncommon case of bilateral pathologic hip fractures: antiviral drug-induced osteomalacia in a patient with hepatitis B. Hip Pelvis 30(2):109–114
Zhu W, Ma Q, Bian Y, Zhuang Q, Xia Z, Jin J, Weng X (2017) Total hip/knee arthroplasty in the treatment of tumor-induced osteomalacia patients: More than 1 year follow-up. PLoS ONE 12(5):e0177835
Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res. 26(7):1381–8
Toomey HE, Toomey SD (1998) Hip arthroplasty in chronic dialysis patients. J Arthroplasty 13(6):647–652
Moya-Angeler J, Lane JM, Rodriguez JA (2017) Metabolic bone diseases and total hip arthroplasty: preventing complications. J Am Acad Orthop Surg 25(11):725–735
Murzic WJ, McCollum DE (1994) Hip arthroplasty for osteonecrosis after renal transplantation. Clin Orthop Relat Res 299:212–219
Yin Z, Du J, Yu F, Xia W (2018) Tumor-induced osteomalacia. Osteoporos Sarcopenia 4(4):119–127
El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) 68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab 101(10):3575–3581
Breer S, Brunkhorst T, Beil FT, Peldschus K, Heiland M, Klutmann S, Barvencik F, Zustin J, Gratz KF, Amling M (2014) 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT. Bone 64:222–227
Eguchi H, Tsuruta M, Tani J, Kuwahara R, Hiromatsu Y (2014) Hypophosphatemic osteomalacia due to drug-induced Fanconi’s syndrome associated with adefovir dipivoxil treatment for hepatitis B. Intern Med 53(3):233–237
Zhang C, Gordon PB, Sutton R, Lentle B (2013) Proximal femoral changes related to bisphosphonate use and looser zones in hypophosphatemic osteomalacia: dual-energy X-ray absorptiometry findings. J Clin Densitom 16(3):380–383
留言 (0)